Late Night Market Recap

 Night.Owl
 
  Night.Owl
 
Follow  Message
 
 
 
Night.Owl masters market recaps, offering sharp analysis that uncovers hidden patterns and key moves. Stay ahead with Night.Owl’s expert insights.
 

•  23 Dec 2025
 

•   AGNC  
   
  0.00%
•   CLX  
   
  0.00%
•   FLY  
   
  0.00%
•   HYMC  
   
  0.00%
•   IVVD  
   
  0.00%

$TRIB Trinity Biotech stole the late-session spotlight after announcing agreements to strengthen its capital structure alongside a major order for nine million TrinScreen HIV tests, signaling renewed demand in global testing markets and fueling explosive volume as traders priced in improved liquidity and growth visibility.

$NVO Novo Nordisk powered higher following FDA approval of its Wegovy oral GLP-1 pill, the first of its kind for weight management, a milestone that reignited optimism around the obesity franchise and drove heavy institutional flow into the stock.

$SOC Sable Offshore extended its powerful rally as approval to restart the Las Flores pipeline reshaped the company’s outlook, with traders responding aggressively to the prospect of restored production and long-awaited regulatory clarity.

$LUNR Intuitive Machines saw choppy but active trading after a reiterated Buy rating from B. Riley Securities, keeping the name on investor radars as analysts continue to frame upside tied to space exploration contracts despite near-term volatility.

$HYMC Hycroft Mining surged to fresh highs after standout exploration drilling results pointed to stronger silver potential than previously modeled, drawing speculative interest as metals-related momentum resurfaced.

$AGNC AGNC Investment traded softer even as Piper Sandler maintained an Overweight rating, with income-focused investors weighing rate expectations against the REIT’s dividend profile.

$NOW ServiceNow slipped modestly as Wall Street digested its $7.75 billion acquisition of cybersecurity firm Armis, a strategic move that expands its AI-driven security footprint but raised short-term valuation and integration questions.

$ZIM ZIM Integrated Shipping attracted renewed attention after shares moved higher on updates tied to its strategic review, keeping shipping names active amid shifting global trade dynamics.

$IVVD Invivyd pulled back despite securing FDA Fast Track status for its COVID antibody therapy, a classic example of near-term profit-taking following regulatory optimism.

$LCID Lucid Group remained under pressure after renewed bearish commentary weighed on sentiment, underscoring ongoing concerns around EV demand and cash burn.

$UMC United Microelectronics drifted lower as investors rotated within the semiconductor space, reflecting broader reassessments of competitive positioning versus larger peers.

$FLY Firefly Aerospace cooled after recent strength tied to Russell 2000 inclusion, with traders locking in gains following a sharp multi-day run.

$ON ON Semiconductor eased as comparative industry analyses highlighted intensifying competition, keeping the stock range-bound despite long-term EV and power chip narratives.

$QCOM Qualcomm edged slightly higher as investors revisited its standing within the semiconductor hierarchy, balancing diversification strengths against cyclical demand signals.

$JHG Janus Henderson Group drew attention after notable ETF flow activity, offering a reminder of how asset allocation trends can ripple into equity performance.

$SOPA Society Pass gained traction on overlooked positive developments in its Southeast Asia e-commerce ecosystem, attracting speculative interest from growth-oriented traders.

$TXN Texas Instruments traded lower as broader semiconductor peer comparisons kept pressure on legacy analog names amid shifting end-market demand.

$STM STMicroelectronics showed modest strength as investors continued to evaluate its competitive stance across automotive and industrial chips.

$MGM MGM Resorts dipped following news of a long-term branding agreement with MGM China, a strategic update that was largely met with a wait-and-see reaction.

$SNY Sanofi edged higher after multiple global regulatory approvals, including EU clearance for Wayrilz and expanded pediatric use of Dupixent, reinforcing confidence in its pipeline depth.

$CLX Clorox slipped after a Bank of America target cut, reflecting ongoing caution around consumer staples heading into 2026.

$RYAAY Ryanair traded lower despite highlighting strong student travel initiatives, as airline investors balanced growth stories against fuel and macro uncertainties.

View All Headlines